BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 27010402)

  • 21. Proton pump inhibitors and severe hypomagnesaemia.
    Cundy T; Mackay J
    Curr Opin Gastroenterol; 2011 Mar; 27(2):180-5. PubMed ID: 20856115
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Could proton pump inhibitors cause cancer?
    Rosch PJ
    Arch Intern Med; 2010 Oct; 170(19):1775-6. PubMed ID: 20975029
    [No Abstract]   [Full Text] [Related]  

  • 23. Proton pump inhibitors and risk of hypomagnesemia.
    Pasina L; Zanotta D; Puricelli S; Djignefa DC; Bonoldi G
    Eur J Intern Med; 2015 Sep; 26(7):e25-6. PubMed ID: 26165831
    [No Abstract]   [Full Text] [Related]  

  • 24. Low Prevalence of Hypomagnesemia in Long-term Recipients of Proton Pump Inhibitors in a Managed Care Cohort.
    Sharara AI; Chalhoub JM; Hammoud N; Harb AH; Sarkis FS; Hamadeh G
    Clin Gastroenterol Hepatol; 2016 Feb; 14(2):317-21. PubMed ID: 26499924
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hypomagnesemia and Hypocalcemia Caused by Proton-Pump Inhibitors Long-Term Therapy.
    Cabras P; Anedda M; Caddeo L; Francesco M; Antonella M
    Am J Ther; 2020; 27(6):e676-e680. PubMed ID: 31425160
    [No Abstract]   [Full Text] [Related]  

  • 26. Proton-pump Inhibitor-induced Severe Hypomagnesemia and Hypocalcemia are Clinically Masked by Thiazide Diuretic.
    Uehara A; Kita Y; Sumi H; Shibagaki Y
    Intern Med; 2019 Aug; 58(15):2201-2205. PubMed ID: 30996187
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An Interesting Case of "Refractory" Hypomagnesemia.
    Koh ZY; Lim SWM; Lim WS
    J Am Med Dir Assoc; 2017 Jul; 18(7):632-633. PubMed ID: 28549719
    [No Abstract]   [Full Text] [Related]  

  • 28. The Association between the Use of Proton Pump Inhibitors and the Risk of Hypomagnesemia in a National Cohort of Veteran Patients with HIV.
    Sutton SS; Magagnoli J; Cummings T; Hardin JW
    J Int Assoc Provid AIDS Care; 2019; 18():2325958218821652. PubMed ID: 30798693
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adverse cardiovascular and blood pressure effects of drug-induced hypomagnesemia.
    Chrysant SG; Chrysant GS
    Expert Opin Drug Saf; 2020 Jan; 19(1):59-67. PubMed ID: 31795777
    [No Abstract]   [Full Text] [Related]  

  • 30. Serious and commonly overlooked side effect of prolonged use of PPI.
    Nand B; Bhagat M
    Am J Med; 2014 Sep; 127(9):e5. PubMed ID: 24927912
    [No Abstract]   [Full Text] [Related]  

  • 31. Hypomagnesaemia due to use of proton pump inhibitors--a review.
    Kuipers MT; Thang HD; Arntzenius AB
    Neth J Med; 2009 May; 67(5):169-72. PubMed ID: 19581665
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Proton pump inhibitor-associated hypomagnesemia: what do FDA data tell us?
    Luk CP; Parsons R; Lee YP; Hughes JD
    Ann Pharmacother; 2013 Jun; 47(6):773-80. PubMed ID: 23632281
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum magnesium and proton-pump inhibitors use: a cross-sectional study.
    Faulhaber GA; Ascoli BM; Lubini A; Mossmann M; Rossi G; Geib G; Furlanetto TW
    Rev Assoc Med Bras (1992); 2013; 59(3):276-9. PubMed ID: 23680271
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Magnesium and Drugs.
    Gröber U
    Int J Mol Sci; 2019 Apr; 20(9):. PubMed ID: 31035385
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Symptomatic hypomagnesemia induced by proton-pump inhibitors (PPIs). A known adverse event that is worth recalling.
    Keco Huerga A; García de la Borbolla Serres J; Castro Fernández M
    Rev Esp Enferm Dig; 2021 Oct; 113(10):728-729. PubMed ID: 33720741
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hypomagnesaemia due to proton-pump inhibitor therapy: a clinical case series.
    Mackay JD; Bladon PT
    QJM; 2010 Jun; 103(6):387-95. PubMed ID: 20378675
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Severe hypomagnesaemia due to proton pump inhibitor use].
    van den Berg S; Scheer MLJ; Holman ND
    Ned Tijdschr Geneeskd; 2018 Aug; 162():. PubMed ID: 30182626
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Severe hypomagnesaemia in long-term users of proton-pump inhibitors.
    Cundy T; Dissanayake A
    Clin Endocrinol (Oxf); 2008 Aug; 69(2):338-41. PubMed ID: 18221401
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Common single nucleotide polymorphisms in transient receptor potential melastatin type 6 increase the risk for proton pump inhibitor-induced hypomagnesemia: a case-control study.
    Hess MW; de Baaij JH; Broekman MM; Bisseling TM; Haarhuis BJ; Tan AC; Te Morsche RH; Hoenderop JG; Bindels RJ; Drenth JP
    Pharmacogenet Genomics; 2017 Mar; 27(3):83-88. PubMed ID: 27926584
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Magnesium and parathyroid hormone levels of patients using different proton pump inhibitors: is there a real link?
    Sarikaya M; Filik L; Ergul B; Doğan Z
    Gastroenterol Nurs; 2013; 36(2):145-8. PubMed ID: 23549219
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.